EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucose Deprivation‐Induced Disulfidptosis via the SLC7A11‐INF2 Axis: Pan‐Cancer Prognostic Exploration and Therapeutic Validation

Zhenyu Song iD, Qiuming Yao, Lina Huang, Dan Cui, Jun Xie, Leilei Wu, Jianfeng Huang, Bo Zhai, Dan Liu iD, Xiao Xu iD

Advanced Science · 2025-10 · 12 (39)

DOI: 10.1002/advs.202408556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.07.2025. Verfasst von Zhenyu Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mini-invasive Interventional Therapy Center, Shanghai East Hospital, Tongji University, 200120, Shanghai, China. Hauptthemen laut MEDLINE: Neoplasms, Glucose, Amino Acid Transport System y+. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Medical University Nanshan Scholars Advanced Talents Foundation, Shanghai Sailing Program, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disulfidptosis, a novel form of regulated cell death, involves cytoskeletal collapse due to excessive disulfide bond formation, linking metabolism and reactive oxygen species to potential cancer therapy targets. Recent multi‐omics studies highlight the prognostic value of disulfidptosis‐related gene (DRG) signatures in pan‐cancers; however, the molecular mechanisms underlying their biological functions and therapeutic relevance remain poorly defined. Herein, a DRG score model is constructed using LASSO Cox regression across 33 cancer types, and a nomogram incorporating the DRG score is developed for prognostic prediction. The tumor microenvironment, mutation profiles, and immunotherapy responses are analyzed. The DRG score serves as an independent prognostic factor across cancers, correlating with poor outcomes and malignant features. Glucose deprivation induces disulfidptosis in SLC7A11 high cells (high SLC7A11 expression), especially in cancers with a high DRG score, such as ovarian cancer. Silencing INF2 prevents disulfidptosis and decreases susceptibility to irofulven, which can be reversed by GLUT inhibitors. SLC7A11 knockdown reduces disulfidptosis, restores ATP/NADPH levels, and protects the cytoskeleton under glucose deprivation, whereas INF2 knockdown impairs cell migration. Moreover, the DRG scores predict prognosis and therapeutic responses. The SLC7A11‐INF2 axis regulates disulfidptosis, migration, and drug sensitivity, highlighting its potential as a marker of metabolic vulnerability in ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsGlucoseAmino Acid Transport System y+HumansPrognosisCell Line, TumorTumor MicroenvironmentDisulfidptosis

Stichwörter der Autor:innen

INF2SLC7A11disulfidptosisovarian cancerpan‐cancer analysisprognosis

Substanzen

GlucoseAmino Acid Transport System y+SLC7A11 protein, human

Autor:innen und Institutionen

  • Mini-invasive Interventional Therapy Center, Shanghai East Hospital, Tongji University, 200120, Shanghai, China.
  • Department of General Practice, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, 200032, China.
  • Department of Rehabilitation Medicine, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, 533000, China.
  • Key Laboratory of Research and Development on Clinical Molecular Diagnosis for High-Incidence Diseases of Baise, Baise, Guangxi, 533000, China.
  • Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

ORCID-Profile: Zhenyu Song, Dan Liu, Xiao Xu

Förderung

  • Guangzhou Medical University Nanshan Scholars Advanced Talents Foundation
  • Shanghai Sailing Program
  • China Postdoctoral Science Foundation
  • Postdoctoral Fellowship Program of China Postdoctoral Science Foundation

Zitieren

APA

Song, Z., Yao, Q., Huang, L., Cui, D., Xie, J., Wu, L., Huang, J., Zhai, B., Liu, D., & Xu, X. (2025). Glucose Deprivation‐Induced Disulfidptosis via the SLC7A11‐INF2 Axis: Pan‐Cancer Prognostic Exploration and Therapeutic Validation. Advanced Science, 12(39). https://doi.org/10.1002/advs.202408556

Vancouver

Song Z, Yao Q, Huang L, Cui D, Xie J, Wu L, et al. Glucose Deprivation‐Induced Disulfidptosis via the SLC7A11‐INF2 Axis: Pan‐Cancer Prognostic Exploration and Therapeutic Validation. Advanced Science. 2025;12(39). doi:10.1002/advs.202408556

BibTeX
@article{Song2025,
  author = {Song, Zhenyu and Yao, Qiuming and Huang, Lina and Cui, Dan and Xie, Jun and Wu, Leilei and Huang, Jianfeng and Zhai, Bo and Liu, Dan and Xu, Xiao},
  title = {Glucose Deprivation‐Induced Disulfidptosis via the SLC7A11‐INF2 Axis: Pan‐Cancer Prognostic Exploration and Therapeutic Validation},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {39},
  doi = {10.1002/advs.202408556}
}
Kostenlos starten →